These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4313165)

  • 1. Effects of l-(2-nitro-l-imidazolyl)-3-methoxy-2-propanol and 2-methyl-5-nitroimidazole-l-ethanol against anaerobic and aerobic bacteria and protozoa.
    Prince HN; Grunberg E; Titsworth E; DeLorenzo WF
    Appl Microbiol; 1969 Nov; 18(5):728-30. PubMed ID: 4313165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of vaginal trichomoniasis with a new anti-protozoal compound ( -chloromethyl-2-methyl-5-nitro-1-imidazole-ethanol).
    Lean TH; Vengadasalam D
    Br J Vener Dis; 1973 Feb; 49(1):69-71. PubMed ID: 4348437
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vitro effect of metronidazole ester on Trichomonas vaginalis and Entamoeba histolytica].
    He Y; Tao X; Guan L; Lian W
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(1):32-4. PubMed ID: 7788891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug targets and mechanisms of resistance in the anaerobic protozoa.
    Upcroft P; Upcroft JA
    Clin Microbiol Rev; 2001 Jan; 14(1):150-64. PubMed ID: 11148007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites.
    Cedillo-Rivera R; Chávez B; González-Robles A; Tapia A; Yépez-Mulia L
    J Eukaryot Microbiol; 2002; 49(3):201-8. PubMed ID: 12120985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of new nitroimidazoles for experimental trichomoniasis, amebiasis, and trypanosomiasis.
    Cuckler AC; Malanga CM; Conroy J
    Am J Trop Med Hyg; 1970 Nov; 19(6):916-25. PubMed ID: 4321789
    [No Abstract]   [Full Text] [Related]  

  • 7. 1,4-Bis-[1-methyl-5-nitroimidazolyl-(2-methyleneimino)]-piperazine, a new drug with marked activity against Entamoeba histolytica. Short communication.
    Raether W; Seidenath H; Winkelmann E
    Arzneimittelforschung; 1977; 27(5):968-9. PubMed ID: 195590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs.
    Edwards DI
    Br J Vener Dis; 1980 Oct; 56(5):285-90. PubMed ID: 7000306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro antiamoebic activity of MK 910 with metronidazole, intestopan and enterovioform.
    De PK; Bhatia VN; Agarwal DS
    Indian J Med Res; 1972 Dec; 60(12):1755-8. PubMed ID: 4351638
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory evaluation of panidazole (1-(2'-( -pyridyl) ethyl-2-methyl)-5-nitroimidazole), a new amoebicide.
    Shapero M; Jefferies HS; Ryan DM
    Ann Trop Med Parasitol; 1972 Jun; 66(2):187-92. PubMed ID: 4338871
    [No Abstract]   [Full Text] [Related]  

  • 11. Metronidazole: in vitro activity, pharmacology and efficacy in anaerobic bacterial infections.
    Tally FP; Sullivan CE
    Pharmacotherapy; 1981; 1(1):28-38. PubMed ID: 6927601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly Potent 1
    Kumar S; Bains T; Won Kim AS; Tam C; Kim J; Cheng LW; Land KM; Debnath A; Kumar V
    Front Cell Infect Microbiol; 2018; 8():380. PubMed ID: 30425970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro trichomonicidal, giardicidal and amebicidal activity of N-acetamide(sulfonamide)-2-methyl-4-nitro-1H-imidazoles.
    Hernández-Núñez E; Tlahuext H; Moo-Puc R; Torres-Gómez H; Reyes-Martínez R; Cedillo-Rivera R; Nava-Zuazo C; Navarrete-Vazquez G
    Eur J Med Chem; 2009 Jul; 44(7):2975-84. PubMed ID: 19208443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiparasitic nitroimidazoles. IV. Serum protein binding and mode of action of 2-(4'-carboxystyryl)-5-nitro-1-vinylimidazole.
    Tarrant ME; Wedley S; Woodage TJ; Green JN
    Biochem Pharmacol; 1973 Mar; 22(5):639-49. PubMed ID: 4348117
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapeutically active nitro compounds. 4. 5-Nitroimidazoles (Part I).
    Winkelmann E; Raether W; Gebert U; Sinharay A
    Arzneimittelforschung; 1977; 27(12):2251-63. PubMed ID: 203293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis.
    Jarrad AM; Debnath A; Miyamoto Y; Hansford KA; Pelingon R; Butler MS; Bains T; Karoli T; Blaskovich MA; Eckmann L; Cooper MA
    Eur J Med Chem; 2016 Sep; 120():353-62. PubMed ID: 27236016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ["In vitro" susceptibility of some aerobic and anaerobic bacteria to three 5-nitro-imidazole derivatives: metronidazole, ornidazole and tinidazole (author's transl)].
    Dublanchet A; Durieux R
    Ann Microbiol (Paris); 1980; 131(1):45-59. PubMed ID: 7362180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitrichomonal activity of 1-[(2,4-dnitropyrryl)-ethyl]-2methyl-5-nitroimidazole and related compounds.
    Brown GW; Wellerson R; Kupferberg AB
    J Pharm Pharmacol; 1965 Nov; 17(11):747-52. PubMed ID: 4379808
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibacterial, antimycotic and trichomonicidal activity of a new nitroimidazole (EU 11100).
    Dubini F; Riviera L; Cocuzza C; Bellotti MG
    J Chemother; 1992 Dec; 4(6):342-6. PubMed ID: 1287136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactivity of Farnesyltransferase Inhibitors Against
    Probst A; Nguyen TN; El-Sakkary N; Skinner D; Suzuki BM; Buckner FS; Gelb MH; Caffrey CR; Debnath A
    Front Cell Infect Microbiol; 2019; 9():180. PubMed ID: 31192168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.